期刊文献+

度洛西汀撤药综合征1例 被引量:1

One Case of Drug Withdrawal Symptoms Caused by Duloxetine
下载PDF
导出
摘要 报道1例41岁男性抑郁症患者应用度洛西汀治疗9月余,突然停药后出现恶心、呕吐、做噩梦、头晕、焦虑不安、易怒、多汗、感觉异常等,复用药物3天后症状消失。本例提示临床在停用度洛西汀时,应逐渐减药,以防止撤药综合征的发生。 This case report described that a 41-year-old male patient with depression was treated with duloxetine for 9 months and following the drug withdrawal the patient developed such symptoms as nausea ,vomiting,nightmare, dizziness,anxiety,irritability,excessive sweating and paraesthesia. The symptoms subsided 3 days after reuse of the medicine. It was indicated that duloxetine should be gradually reduced when it is going to be stopped for use so as to avoid the occurrence of drug withdrawal symptoms.
出处 《中国执业药师》 CAS 2013年第8期29-29,31,共2页 China Licensed Pharmacist
关键词 度洛西汀 药品不良反应 撤药综合征 Duloxetine Adverse Drug Reaction Drug Withdrawal Symptoms
  • 相关文献

参考文献3

  • 1徐静,于相芬.度洛西汀的临床应用进展[J].西南军医,2011,12(4):695-698. 被引量:17
  • 2Perahia DG, Kajdasz DK, Desaiah D, et al. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder[J]. J Affect Disord, 2005,89(1-3): 207- 212.
  • 3喻东山,葛茂宏.精神科合理用药手册[M].2版.南京:江苏凤凰科学技术出版社有限公司,2011.

二级参考文献24

  • 1Cupta S, Nihalani N, Masand P. Duloxetine:review of its pharmacolo- gy,and therapeutic use in depression and other psyehiatrle disorders [ J]. Ann Clin Psychiatry,2007,19(2) : 125 - 132.
  • 2Rabassedax. Duloxetine: a new serotonin/noradrenaline reuptake in- hibitor for the treatment of depression [J]. Drugs Today( Bare), 2004,40(9) :773 -790.
  • 3Trivedi MH, Desaiah D, Ossanna Mj, et al. Clinical evidence for sero- tonin and norepinephrine reuptake inhibition of duloxetine [J]. Int Clin Psychopharmaco1,2008,23 (3) : 161 - 169.
  • 4Thase ME, Pritchett YL, Ossanna MJ,et al. Efficacy of duloxetine andselective serotonin reuptake inhibitors :comparisons as assessed by re- mission rates in patients with major depressive disorder [ J]. J Clin Psychopharmaco1,2007,27 ( 6 ) : 672 - 676.
  • 5Mallinckrodt CH, Prakash A, Houston JP, et al. Differential antide- pressant symptom efficacy: placebo - controlled comparisons of duloxe- tine and SSRIs ( fluoxetine, paroxetine, escitalopram ) [ J]. Neuropay- chobiology ,2007,56 (2 - 3 ) :73 - 85.
  • 6Hirschfeld RM, Vomik LA. Newer antidepressants: reviews of efficacy and safety of eseitalopram and duloxetine [J]. J Clin Psychiatry, 2004,65 (Suppl4) :46 - 52.
  • 7Brecht S, Courtecuisse C, Debieuvre C, et al. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients withmajor depressive disorder and at least moderate pain of unknown ctiol- ogy:a randomized controlled trial [J]. J Clin Psychiatry, 2007, 68 (11) :1707 -1716.
  • 8Fava M, Martinez JM, Greist J , et al. The efficacy and tolerability of duloxetine in the treatment of anxious versus non - anxious depres- sion:a post - hoc analysis of an open - label outpatient study [J] . Ann Clin Psychiatry ,2007,19 ( 3 ) : 187 - 195.
  • 9Smith T, Nieholson RA. Review of duloxetine in the management of diabetic peripheral neuropathic pain [J]. Vase Health Risk Manag, 2007,3(6) :833 -844.
  • 10Raskln J, Pritchett YL, Wang F, et al. A double -bllnd,random/zed muhicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain [ J ]. Pain Med, 2005,6 ( 5 ) : 346 - 356.

共引文献36

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部